Traffic Lights - Latest Updates

Last updated: 05/09/2022

Other updates on this site
Drug Name Classification Clinical Indication Comments
ATOMOXETINE (UPDATED) Orange Attention deficit hyperactivity disorder (ADHD)

Adults
Full SCA

Children and adolescents
Full SCA

 

AZATHIOPRINE (UPDATED) Orange Dermatological disease

Full SCA

AZATHIOPRINE (UPDATED) Orange Rheumatological disease

Full SCA

BIJUVE (Estradiol and Progesterone combined) (NEW) Green Indicated for continuous combined hormone replacement therapy (HRT) for estrogen deficiency symptoms in postmenopausal women with intact uterus and with at least 12 months since last menses.
CICLOSPORIN Oral (UPDATED) Orange Dermatological disease

Full SCA

CYANOCOBALAMIN Do not prescribe Dietary supplementation of Vitamin B12
CYANOCOBALAMIN (Orobalin ®1mg tablet) Green Higher strength cyanocobalamin oral product

Only to be used where there is malabsorption of Vitamin B12 in needle phobic patients, patients with mobility issues unable/ unsuitable to attend for injections or patients where injection is not tolerated preventing the use of hydroxycobalamin injections.

CYTISINE (NEW) Red Smoking cessation
DEXAMFETAMINE (UPDATED) Orange Attention deficit hyperactivity disorder (ADHD)

Adults
Full SCA

Children and adolescents
Full SCA

DEXAMFETAMINE (UPDATED) Orange Excessive sleepiness caused by narcolepsy

SCA

ENALAPRIL MALEATE (Orodispersible tablet - Aqumeldi) (NEW) Orange Treatment of heart failure in children from birth to less than 18 years.

Not licensed in Adults

GUANFACINE (UPDATED) Orange ADHD - Peadiatric

Paediatric Full SCA and Request Form

HYDROXYCARBAMIDE (UPDATED) Orange Myeloproliferative disorders, sickle cell anaemia

Full SCA

ICOSAPENT ETHYL (Vazkepa ®) (UPDATED) Green Raised triglycerides in patients with CVD
LEFLUNOMIDE (UPDATED) Orange Rheumatological disease

Full SCA     Request form

LISDEXAMFETAMINE DIMESYLATE (UPDATED) Orange ADHD when response to methylphenidate is inadequate

Adults
Full SCA

Children and adolescents
Full SCA

MERCAPTOPURINE (UPDATED) Orange Inflammatory Bowel Disease (Ulcerative Colitis, Crohn's Disease) & Autoimmune Hepatitis

Full SCA

METHOTREXATE Oral (UPDATED) Orange Crohn's Disease

Full SCA

METHOTREXATE Oral (UPDATED) Orange Dermatological disease

Full SCA

METHOTREXATE Oral (UPDATED) Orange Rheumatological disease

Full SCA     Request form

METHYLPHENIDATE (UPDATED) Orange Excessive sleepiness caused by narcolepsy

SCA

METHYLPHENIDATE (+'CR') (UPDATED) Orange Attention deficit hyperactivity disorder (ADHD)- prescribe CR formulation by brand name only

For information about products please see relevant Shared Care.
Adults:  Full SCA
Children & adolescents:  Full SCA

MYCOPHENOLATE MOFETIL (UPDATED) Orange Autoimmune conditions

Please see shared care agreement for individual indications

PENICILLAMINE (UPDATED) Orange Rheumatoid arthritis

Full SCA

SULFASALAZINE (UPDATED) Orange Rheumatological disease

Full SCA

Other Updates on this Website

Recent documents from LLR APC and TAS


About the Leicester, Leicestershire and Rutland Area Prescribing Committee

In common with other local health communities, the Leicester, Leicestershire and Rutland Area Prescribing Committee (LLR APC) acknowledges the benefits of having a Leicestershire Health Community-wide strategy for the prescribing of specialist medicines and the managed entry of new drugs and related technologies.

Leicestershire Health Community comprises the Leicester, Leicestershire and Rutland Integrated Care Board, University Hospitals of Leicester (UHL) NHS Trust and Leicestershire Partnership NHS Trust (LPT), amongst which there is a total consensus on the need for this strategy, and the LLR APC has been in place since 2005. Learn more